Digipath
Home > Boards > US OTC > Miscellaneous >

India Globalization Capital Inc. (IGCC)

IGCC RSS Feed
Add IGCC Price Alert      Hide Sticky   Hide Intro
Moderator:
Search This Board: 
Last Post: 1/14/2019 8:43:18 AM - Followers: 161 - Board type: Free - Posts Today: 0

165 FOLLOWERS AS OF 10/14/2018 
iBox Update 10/14/2018 11:35 CrazyKar123
 

India Globalization Capital, Inc. (NYSE MKT: IGC) is a first mover in developing a portfolio of products using cannabis-based "combination therapies" for the treatment of pain and other conditions.

IGC's strategy is exciting and unique in that it is aiming to become a leader in the phytocannabinoid-based combination therapy specialty pharmaceutical sector. This first-mover advantage can potentially be formidable as it begins clinical trials and further builds its patent portfolio

IGC recently exited its legacy businesses and currently holds international investments in land and in a hotel project.

 

Investment Highlights

• Building a patented portfolio of phytocannabinoid-based pharmaceutical and nutraceutical products for one of the world's fastest growing industries
• Positioning for first-mover advantage by developing novel therapies, applying for patents, and acquiring technologies from related industries
• Strategic alliance with International Pharma Trials provides expertise in the FDA process and pharma-trials

 


Development Pipeline

Through cutting-edge research, IGC is developing a product portfolio of phytocannabinoid-based therapies for the treatment of a wide range of life altering or life threatening indications, including neuropathic and cancer pain, epilepsy, end of life supportive care, adjunctive supportive therapies of chronic neurological and oncological diagnosis.


Target Markets

Attitudes toward cannabis have transformed substantially across the United States. Support for cannabis legalization is rapidly outpacing opposition; 53 percent of Americans believe cannabis should be made legal, compared with 44 percent supporting illegality of cannabis. Within this burgeoning market, IGC has identified key areas to which it can apply its phytocannabinoid-based therapies to address unmet medical needs.

 

Pain

The treatment of pain is a great challenge for health care professionals as it can often debilitate individuals in ways that affect their day-to-day functioning, which significantly impacts the nation's productivity and economy. The national cost of health care due to pain ranges from $560 billion to $635 billion. In addition, the health care cost attributed to the abuse of prescription opioids, closely related to pain, is approximately $25 billion.

A major disadvantage of using currently available drug therapies to treat chronic severe pain is that these opioid based drugs may lead to side effects like hallucinations, constipation, sedation, nausea, respiratory depression, and dysphoria.

IGC-501

IGC has applied for a U.S patent based on a novel therapy, IGC-502 indicated for seizures, using cannabinoid extracts. The therapy is administered, using a variety of delivery technologies, for indications in mammals such as dogs and cats. The therapy may also be useful in humans.

IGC expects to conduct metabolic profiling and apply to the FDA for trials over the next few years.

 

Epilepsy

Approximately 50 million people worldwide are affected by epilepsy (Sanders, 2003), a condition attributed to multiple factors. In dogs and cats, seizures are often caused by abnormal brain activity. They can be subtle or cause violent convulsions. Some seizures only occur once, but repeated seizures require treatment to prevent larger areas of the brain from becoming affected.

IGC-502

IGC has applied for a U.S patent based on a novel therapy, IGC-502 indicated for seizures, using cannabinoid extracts. The therapy is administered, using a variety of delivery technologies, for indications in mammals such as dogs and cats. The therapy may also be useful in humans.

IGC expects to conduct metabolic profiling and apply to the FDA for trials over the next few years.

 

Eating Disorders

Cachexia is a condition that accompanies severe illness such as cancer and results in the weakness and wasting away of the body. Approximately 1.3 million people in the United States are experiencing cachexia associated with cancer, multiple sclerosis, Parkinson's disease, HIV/AIDS, and other progressive illnesses. Notably, cancer-induced anorexia/cachexia is responsible for about 20% of all cancer deaths.

IGC-504 and IGC-506

Indicated for a variety of eating disorders, including cachexia, IGC-504 and IGC 506 are unique combination therapies that, if proven out by clinical trials, are expected to treat medical refractory epilepsy and eating disorders respectively, with lower side effects than conventional mono therapies. IGC-506 is being developed for both human and veterinary use.

 


Industry Partnerships

IGC has established a strategic alliance with International Pharma Trials, whose doctors and researchers have expertise in disorders of the central and peripheral nervous system as well as expertise in the FDA process and pharma-trials.

The company continues to seek information exchanges with medical cannabis dispensaries, research scientists, doctors, medical and business professionals, and biotech companies working in the cannabinoid space.

Leveraging its business model and collaborative research, IGC can help commercialize products while finding innovative ways of helping patients benefit from cannabinoids.

 


Leadership


Ram Mukunda, President, CEO and Director

Ram Mukunda has served as IGC's executive chairman, chief executive officer, and president since the company's inception on April 29, 2005. From January 1990 to May 2004, Mukunda served as founder, chairman, and chief executive officer of Startec Global Communications, an international telecommunications carrier focused on providing voice over Internet protocol (VOIP) services to emerging economies. Startec was the first pure play international long distance carrier. Mukunda was responsible for organizing, structuring and integrating a number of companies owned by Startec. Under Mukunda's tenure at Startec, the company made an IPO of its equity securities in 1997 on NASDAQ. Prior to Startec, Mr. Mukunda served as Strategic Planning Advisor at Intelsat, a communications satellite services provider.

Mukunda serves as an emeritus member on the Board of Visitors at the University of Maryland, School of Engineering. From 2001 to 2003, he was a council member at Harvard's Kennedy School of Government, Belfer Center of Science and International Affairs.

Mukunda is the recipient of several awards including, the 2013 University of Maryland's International Alumnus of the Year award, the 2001 Distinguished Engineering Alumnus Award, the 1998 Ernst & Young, LLP's Entrepreneur of the Year Award. He holds a B.S. degree in Electrical Engineering, a B.S degree in Mathematics, and a M.S. in Engineering from the University of Maryland.

John Cherin, CFO, Treasurer, PAO

John Cherin is a retired senior executive with international experience in assisting young companies. He has provided insight to top management and Board of Directors on strategic analysis and improvement of operating procedures in financial reporting and operations. From 1966 to 1997, Cherin gained his experience as a senior partner at Arthur Andersen while managing practices aimed at businesses in the US and overseas. In addition he founded and managed Cherin Global Consulting in 1997-2005 and the Cherin Group LLC in 2004 to date. He also served as CFO for IGC in its formative stages for the purpose of raising capital to enable IGC's launch in the post startup phase.

Cherin is a retired CPA, a graduate of Northeastern University class of 1966 and in 1967 was the Silver Medal Recipient from the Massachusetts Society of CPAs.

Claudia Grimaldi, General Manager, Director of Cabaran Ultima

Claudia Grimaldi is the general manager and director of IGC's project development and managing company in Malaysia. Grimaldi is responsible for coordinating the staff in various countries and ensuring timely and accurate regulatory compliance and statutory reporting. Prior to assuming her current role in 2013, she spent three years managing the office of the CEO.

Prior to IGC, Grimaldi worked in human resources and psychotherapy. She graduated Summa Cum Laude from Javeriana University, a top five University in Colombia, with a Bachelor of Arts in Psychology. She holds an MBA in General Management, graduating with Highest Honors, from Meredith College. Grimaldi is a member of Delta Mu Delta International Honor Society. She is also fluent in both English and Spanish.

 


India Globalization Capital
PO BOX 60642
Potomac, MD 20859-0642
Phone: (301) 983-0998
www.IGCinc.us

NetworkNewsWire
1324 Lexington Ave.
Suite 117
New York, NY 10128
Phone: (212) 418-1217
www.NetworkNewsWire.com

 

NetworkNewsWire is a moderator of this board. Please see disclaimer on the NetworkNewsWire website: https://www.networknewswire.com/disclaimer/





 








https://www.otcmarkets.com/stock/IGC/security









 











 

Digipath
IGCC
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
IGCC News: NYSE American to Suspend Trading in India Globalization Capital and Commence Delisting Proceedings 10/29/2018 06:40:00 PM
IGCC News: IGC Announces Financial Results for Quarter Ended September 30, 2018 10/16/2018 08:00:00 AM
IGCC News: Quarterly Report (10-q) 10/16/2018 06:03:33 AM
IGCC News: Securities Registration Statement (simplified Form) (s-3) 10/15/2018 05:34:52 PM
IGCC News: SeeThru Equity Announces Increased Target for American Premium Water Corporation (OTC:HIPH) 10/10/2018 09:30:00 AM
PlusOneCoin Top Posts
No plusone'd posts yet. Be the first!
PostSubject
#6528   Time to bounce https://stockcharts.com/public/1164099 cottonmather 01/14/19 08:43:18 AM
#6527   May I ask who do you guys think Smilin_B 01/07/19 05:17:03 PM
#6526   Where is Ram at these days? What business Smilin_B 01/03/19 02:04:01 AM
#6525   Looks like i was right Smilin_B 01/02/19 02:42:00 PM
#6524   lol I agree. Milo1 01/02/19 11:02:17 AM
#6523   lol no, baldingcontrarian 01/02/19 11:01:16 AM
#6522   May want to go back to $10... Milo1 01/02/19 10:35:51 AM
#6521   Long .315 for 6000 baldingcontrarian 12/29/18 10:59:38 PM
#6520   Im thinking, at some point this stock may Smilin_B 12/29/18 10:39:50 AM
#6519   I have been following rams scan since 2002 manofIsle 12/26/18 03:57:01 PM
#6518   RAM HAS BEEN SELLING STOCK AND DOING RS manofIsle 12/26/18 03:50:16 PM
#6517   gotcha Rocketstockpix 12/21/18 10:55:47 AM
#6516   Yes Fraud and delisted by the SEC happened Simply read Smilin_B 12/21/18 10:53:14 AM
#6515   wasn't this a 15.00 stock under the symbol Rocketstockpix 12/21/18 10:51:20 AM
#6514   just login to your trade account, input igcc Alexxdj1 12/05/18 10:39:35 PM
#6513   That's because it is a crack whore hotel!!!, Alexxdj1 12/05/18 10:37:51 PM
#6512   Did you happen to look at the photographs Smilin_B 12/04/18 02:26:21 AM
#6511   How would I go about busying shares again?? LHP93 12/03/18 10:45:26 AM
#6510   Wild ride Alexxdj1 12/02/18 11:31:58 PM
#6509   Correct it was delisted cause it was a jonsmile 12/02/18 10:01:04 PM
#6508   total scheme, got delisted. that is all she wrote. Alexxdj1 12/02/18 09:44:12 PM
#6507   CBD Drinks Heating up https://www.cannabisnewswire.com/cannabisnewsbreaks/cannab MazelTov 11/30/18 11:37:21 AM
#6506   I DID AT 49 CENTS PER/ DAMM GLAD TOO toby3 11/29/18 06:52:33 PM
#6505   Buy yourself some candy Smilin_B 11/29/18 03:15:07 PM
#6504   Lol I told you guys Buy didn't I???? mulder35 11/29/18 12:38:18 PM
#6503   Realtime Posts are awesome Smilin_B 11/29/18 02:27:45 AM
#6502   Im back in at 49 cents toby3 11/28/18 05:28:40 PM
#6501   Buy Now orrr risk it getting away from mulder35 11/28/18 01:38:02 PM
#6500   They will just RS corncakes0 11/28/18 12:11:05 PM
#6499   I'm not in and I find that a corncakes0 11/28/18 12:09:08 PM
#6498   No! I will buy around .70 & sell Id StockUser 11/28/18 11:31:03 AM
#6497   Translates to YES ITS A BUY! mulder35 11/28/18 11:13:53 AM
#6496   Ab tera kya hoga Ram ji? Id StockUser 11/28/18 10:23:53 AM
#6495   Hmmm 60 Cents Plus! As I was Saying Yesterday... mulder35 11/28/18 10:09:59 AM
#6494   So where did this $29,968,187.50 in cash proceeds go? Smilin_B 11/28/18 05:32:02 AM
#6493   Are these entities that paid $5.30/share for a Smilin_B 11/28/18 04:10:51 AM
#6492   IGC down yet ANOTHER 23% on the day. Where Smilin_B 11/27/18 08:40:04 PM
#6491   Wow... and you believe this figure? Smilin_B 11/27/18 02:11:31 PM
#6490   I Dont CARE. They have 30 M @ mulder35 11/27/18 02:00:55 PM
#6489   You very well may be accurate but did Smilin_B 11/27/18 12:31:23 PM
#6488   Keep Selling This is Wound up Too TIGHT... mulder35 11/27/18 09:39:48 AM
#6487   This article FULLY explains the SCAM that Ram Smilin_B 11/27/18 04:50:17 AM
#6486   Piece of dog poo this turned out to Smilin_B 11/26/18 05:10:05 PM
#6485   https://www.marketwatch.com/story/the-collapse-of-this-cannabis-shock-offers-a-v davidsson10 11/26/18 10:41:38 AM
#6484   that pop couldn't sustain , this stock appears JAH son 11/23/18 01:55:30 AM
#6483   Dead Silence in here Smilin_B 11/20/18 08:07:05 PM
#6482   What was the latest scam exposure to hit IGCC? Smilin_B 11/19/18 03:40:24 AM
#6481   How bout those warrants? Smilin_B 11/18/18 02:30:07 AM
#6480   .04 today no? Smilin_B 11/15/18 09:11:57 PM
#6479   Pretty soon will be trading on sub pennies Las_Vegas 11/15/18 08:14:48 PM
PostSubject